From pathway engineering to gene therapy vectors and pooled libraries, F1-X™ Next-Gen Gibson Assembly delivers reliable, one-step multi-fragment assembly with high-fidelity joins.
Build and iterate faster with fewer errors.
Precision cloning for viral vector development.
Seamless construction of gRNA and donor libraries.
Assemble and preserve high- integrity, multi-kilobase constructs.
Build and iterate faster with fewer errors.
F1-X™ Next-Gen Gibson Assembly enables rapid design–test cycles by assembling multi-gene operons, tunable promoters, regulatory cassettes, and pathway modules in a single, one-step reaction. It supports scarless joins across multi-fragment, so teams can iterate metabolic and synthetic circuits quickly—with fewer bottlenecks and higher fidelity.
Use Cases:
Why It Works:
Fast, one-tube reactions reduce hands-on time, while high-fidelity enzymes reduce junction errors and preserve design logic.
Precision cloning for viral vector development.
F1-X™ Next-Gen Gibson Assembly is built for complex gene therapy constructs, including AAV and lentiviral expression cassettes. High-fidelity, scarless joins preserve regulatory elements, payloads, and UTRs across fragments—helping maintain ITR/LTR integrity and reducing design-related recombination risks.
Use Cases:
Why It Works:
High-fidelity assembly with up to multiple fragments in one step allows you to customize vectors while keeping essential regulatory features intact.
Seamless construction of gRNA and donor libraries.
F1-X™ Next-Gen Gibson Assembly streamlines pooled or plate-based CRISPR assemblies. Assemble gRNA cassettes (U6 promoter, gRNA scaffold, tracrRNA) or HDR donors with homology arms and payloads in a single, one-step reaction. High-fidelity, scarless junctions help maintain guide architecture and minimize ligation artifacts multiple fragments.
Use Cases:
Why It Works:
Scar-free joins and reliable multi-fragment assembly reduce the risk of dropout, enabling higher library fidelity and consistent functional output.
Assemble and preserve high-integrity, multi-kilobase constructs.
For synthetic DNA storage, enzyme pathway archiving, and vector backbone refactoring, F1-X™ Next-Gen Gibson Assembly delivers high-fidelity multi-fragment builds with 3-5+ kb per fragment, scarless junctions, and low error rates—built for scenarios where structural accuracy and integrity are non-negotiable.
Use Cases:
Why It Works:
The high-fidelity polymerase and ligation-optimized mix preserve long reads and structure. No need for cleanup, gel extraction, or overlap re-design.
Discovery teams screening large antibody or enzyme panels need fast, reliable cloning. F1-X™ Next-Gen Gibson Assembly enables one-step, multi-fragment assembly and straightforward combinatorial libraries with high fidelity.
Accelerates biopharma R&D, protein-engineering programs, and labs focused on therapeutic or industrial enzyme evolution.
High-throughput labs and synthetic-biology foundries rely on automation to keep pace with build–test–learn cycles. F1-X™ Next-Gen Gibson Assembly is a single-tube, isothermal reaction that drops into robotic liquid-handling and LIMS-linked workflows—robots combine DNA fragments with the F1-X™ Master Mix, incubate, and move on—no thermocycling or multi-step ligations.
Ideal for synthetic-biology teams, academic core facilities, and biotech startups that want cloning to be a push-button step.
Rapid mRNA workflows depend on accurate, scarless DNA templates spanning UTRs and antigen or therapeutic sequences. F1-X™ Next-Gen Gibson Assembly links these elements into a single plasmid in one step—with no extra bases at junctions and high-fidelity performance.
Perfect for vaccine developers, therapeutic mRNA teams, and academic groups exploring next-generation RNA medicines.
Cell-free plasmid amplification directly from Gibson assemblies. Generate µg-scale DNA in 2–6 hours—no E. coli recovery or overnight cultures. Ideal for IVT, sequencing, and protein workflows where cells are a drag on productivity.
A Vibrio natriegens expression system for fast growth and strong titers. T7-system compatible with low endotoxin—built for challenging targets and rapid iteration.